The Paragon Report Provides Stock Research on SunPower and First Solar
Continue ReadingTag: research-reports
Biotech Industry Experiencing More FDA New Drug Approvals in 2012
Five Star Equities Provides Stock Research on Acorda Therapeutics and Peregrine Pharmaceuticals
Continue Reading
Amyris and Solazyme Shares Surge as Alternative Fuels Tax Credit Extended Through 2013
Five Star Equities Provides Stock Research on Amyris and Solazyme
Continue Reading
Chinese Solar Stocks on an Impressive Run to Start the Year After a Dismal 2012
The Paragon Report Provides Stock Research on LDK Solar and Trina Solar
Continue Reading
Renewable Energy and Alternative Fuels Stocks Rally as Deal to Avoid “Fiscal Cliff” Extends Industry Tax Credits
Five Star Equities Provides Stock Research on Renewable Energy Group and Gevo
Continue Reading
Gold Prices Surge as Deal to Avoid Fiscal Cliff “Within Sight”
The Paragon Report Provides Stock Research on Eldorado Gold and Kinross Gold
Continue Reading
Gold Posts 12th Consecutive Year of Gains With a 6% Increase in 2012
The Paragon Report Provides Stock Research on Yamana Gold and New Gold
Continue Reading
S&P 500 Index Posts a 13.4% Gain in 2012 — The Largest Since 2009
The Paragon Report Provides Stock Research on Caterpillar and Halliburton
Continue Reading
S&P 500 Index Posts Best Year Since 2009 — Bristol Myers Squibb and Johnson & Johnson Receive FDA Approvals
The Paragon Report Provides Stock Research on Bristol Myers Squibb and Johnson & Johnson
Continue Reading
China-s Sets First Round of 2013 Rare Earth Exports 27% Below 2012
Five Star Equities Provides Stock Research on Molycorp and Lynas
Continue Reading